Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Prostatic Neoplasms × Radiotherapy × Clear all

Phase

Phase 2 49 Phase 3 41 Phase NA 25 Phase 1 13 Phase 1/2 8 Phase EARLY_PHASE1 1 Phase 4 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Anemia 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Oropharyngeal Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Mouth Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Promyelocytic, Acute 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Zoledronic Acid 9 Leuprolide 8 luprolide acetate gel depot 5 enzalutamide 5 bicalutamide 5 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5 Triptorelin Pamoate 4 Dutasteride 4 darolutamide 3 Magnetic Resonance Spectroscopy 3 Goserelin 3 Flutamide 3 Androgen Antagonists 3 Abiraterone Acetate 3 fluciclovine F-18 2 Sodium Chloride 2 Propofol 2 Prednisone 2 Prednisolone 2 Gonadotropin-Releasing Hormone 2 Finasteride 2 Dexamethasone 2 Desflurane 2 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2 testosterone 17 beta-cypionate 1 semaglutide 1 polyethylene glycol 3350 1 pegylated granulocyte colony-stimulating factor, human 1 pasireotide 1 gadoteridol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00590213 2008-01-25

COMART

AstraZeneca

Phase 4 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡